Interleukin-31 promotes pathogenic mechanisms underlying skin and lung fibrosis in scleroderma
- 1 September 2020
- journal article
- research article
- Published by Oxford University Press (OUP) in Rheumatology
- Vol. 59 (9), 2625-2636
- https://doi.org/10.1093/rheumatology/keaa195
Abstract
Objectives. Cytokines released by infiltrating T cells may promote mechanisms leading to fibrosis in scleroderma. The aim of this study was to investigate the role of the Th2 cytokine IL-31, and its receptor IL-31RA, in scleroderma skin and lung fibrosis. Methods. IL-31 was measured by ELISA of plasma, and by immunochemistry of fibrotic skin and lung tissue of scleroderma patients. The receptor, IL-31RA, was assayed by qPCR of tissue resident cells. Next-generation sequencing was used to profile the responses of normal skin fibroblasts to IL-31. In wild-type Balb/c mice, IL-31 was administered by subcutaneous mini pump, with or without additional TGF beta, and the fibrotic reaction measured by histology and ELISA of plasma. Results. IL-31 was present at high levels in plasma and fibrotic skin and lung lesions in a subset of scleroderma patients, and the receptor overexpressed by downstream cells relevant to the disease process, including skin and lung fibroblasts, through loss of epigenetic regulation by miR326. In skin fibroblasts, IL-31 induced next generation sequencing profiles associated with cellular growth and proliferation, anaerobic metabolism and mineralization, and negatively associated with angiogenesis and vascular repair, as well as promoting phenotype changes including migration and collagen protein release via pSTAT3, resembling the activation state in the disease. In mice, IL-31 induced skin and lung fibrosis. No synergy was seen with TGF beta, which supressed IL-31RA. Conclusion. IL-31/IL-31RA is confirmed as a candidate pro-fibrotic pathway, which may contribute to skin and lung fibrosis in a subset of scleroderma patients.Funding Information
- Rosetrees Trust
- Royal Free Charity
- Scleroderma & Raynaud’s
This publication has 33 references indexed in Scilit:
- Platelet-derived growth factor alpha and beta receptors have overlapping functional activities towards fibroblastsFibrogenesis & Tissue Repair, 2013
- Activation of Eosinophils Interacting with Dermal Fibroblasts by Pruritogenic Cytokine IL-31 and Alarmin IL-33: Implications in Atopic DermatitisPLOS ONE, 2012
- IL-31 Serum Protein and Tissue mRNA Levels in Patients with Atopic DermatitisAnnals of Dermatology, 2011
- Structures and biological functions of IL-31 and IL-31 receptorsCytokine & Growth Factor Reviews, 2008
- Molecular Subsets in the Gene Expression Signatures of Scleroderma SkinPLOS ONE, 2008
- Standardized quantification of pulmonary fibrosis in histological samplesBioTechniques, 2008
- Interleukin‐31 induces cytokine and chemokine production from human bronchial epithelial cells through activation of mitogen‐activated protein kinase signalling pathways: implications for the allergic responseImmunology, 2007
- A randomized, controlled trial of methotrexate versus placebo in early diffuse sclerodermaArthritis & Rheumatism, 2001
- Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4.JCI Insight, 1992
- Cellular infiltrates in scleroderma skinArthritis & Rheumatism, 1977